Marker Therapeutics Inc.
MRKR | NASDAQ
$1.20
+$0.02 (+1.69%)
At close: Sep 21, 2026, 4:00 PM ET
$1.20
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.89 | -2.61 | -2.85 | -0.74 | -1.74 | -2.38 |
PEG Ratio | 0.06 | 0.07 | 0.06 | 0.02 | 0.17 | -0.08 |
PS Ratio | n/a | 4.24 | 14.63 | 6.32 | 58.55 | 146.12 |
PB Ratio | 1.36 | 1.50 | 3.45 | 1.13 | 1.65 | 2.49 |
P/FCF Ratio | -1.90 | -2.56 | -2.95 | -0.82 | -2.39 | -2.33 |
P/OCF Ratio | -1.90 | -2.56 | -2.95 | -0.82 | -2.66 | -3.40 |
OCF/S Ratio | n/a | -165.53 | -496.51 | -767.66 | -2.2K | -4.29K |
Debt / Equity Ratio | n/a | n/a | n/a | 0.39 | 0.27 | 0.45 |
Quick Ratio | 8.39 | 6.36 | 5.89 | 2.14 | 3.56 | 3.81 |
Current Ratio | 8.39 | 6.36 | 5.57 | 2.14 | 3.56 | 3.81 |
Asset Turnover | n/a | 0.30 | 0.19 | 0.10 | 0.02 | 0.01 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -72.42% | -57.82% | -58.61% | -152.70% | -95.21% | -104.98% |
Return on Assets | -63.78% | -48.73% | -48.09% | -86.95% | -61.46% | -62.93% |
Return on Invested Capital | -76.65% | -59.91% | -103.76% | -72.71% | -70.68% | -72.94% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -104.33% | -214.60% | -240.64% | -154.70% | -3.94K% |
Net Profit Margin | n/a | -162.82% | -248.76% | -851.87% | -3.37K% | -6.15K% |
Pretax Profit Margin | n/a | -162.06% | -424.09% | -562.85% | -3.37K% | -6.15K% |
Operating Profit Margin | n/a | -168.69% | -440.37% | -563.28% | -3.18K% | -6.19K% |
FCF Margin | n/a | -165.53% | -496.51% | -767.66% | -2.45K% | -6.27K% |
EBITDA Margin | n/a | -162.06% | -339.86% | -483.47% | -3.12K% | -5.92K% |
Add to Watchlist
Select watchlists to add or remove MRKR